According to the Union health ministry, the ICMR will begin nationwide serosurveys to assess the spread of COVID-19, and all states/UTs should be encouraged to conduct these so that data from all geographies may be obtained. The ministry also stated that the country’s Covid situation seemed to be stabilizing, but advised citizens to maintain acceptable behavior and social distance rules.
“The Indian Council of Medical Research (ICMR) will undertake nationwide serosurveys to assess the spread of Covid, and states/UTs should undertake them as well,” it stated.
Since the highest reported peak in daily cases on May 7, India has seen a nearly 78 percent reduction in daily new COVID-19 cases, according to the government.
It further stated that the weekly COVID-19 positive rate has decreased by 74% from the peak incidence of 21.6 percent was reported between April 30 and May 6.
Breaking the transmission cycle, according to the Center, means less load on the health infrastructure and higher care quality.
“We respect each country’s regulatory system, but it will have no impact on India’s vaccine program,” the health ministry said in response to the US Food and Drug Administration (FDA) denying Bharat Biotech’s COVID-19 vaccine Covaxin an Emergency Use Authorization (EUA).